Regen Biopharma INC (RGBPP) — 10-K Filings
All 10-K filings from Regen Biopharma INC. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Regen BioPharma: No Revenue, Focus on Early-Stage Biotech Pipeline
— Dec 30, 2025 Risk: high
Regen BioPharma Inc. (RGBPP) reported no revenue for the fiscal year ending September 30, 2025, as it remains a development-stage biotechnology company focused -
Regen BioPharma Files 2024 10-K
— May 13, 2025 Risk: medium
Regen BioPharma Inc. filed its 10-K for the fiscal year ending September 30, 2024, reporting on its operations and financial condition. The company, incorporate
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX